InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.33
(
0.48%
)
Bitcoin
58,569.37
(
-2.65%
)
Post# of 252484
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119978
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: natvik post# 42446

Saturday, 02/24/2007 3:46:22 PM

Saturday, February 24, 2007 3:46:22 PM

Post# of 252484
>Throw out ANA380 - what value does that give ANDS?<

That depends greatly on whether they can get ANA975 back into the clinic. Without ANA975, the situation would be bleak, IMO.

After the CEO’s sudden departure last year—timed perfectly to preempt the announcement that ANA975 was on clinical hold—ANDS is not likely to get the benefit of the doubt from the investment community.

>Do you - or does anyone - have any feel for their antibacterial program?<

Sorry, I don’t.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up